Navigation Links
Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
Date:5/21/2008

BERKELEY HEIGHTS, N.J., May 21 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced that multiple abstracts featuring its lead oncology products will be featured at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30 - June 3, 2008.

The abstracts include the following:

-- Initial Phase 1 Clinical and Pharmacokinetic Assessment of G4544, an

oral gallium-containing Compound. Poster # 53C Abstract No: 8592

Saturday, May 31, 2008.

-- A Phase I/II Study to Determine the Feasibility and Efficacy of the

Triple Combination of Oblimersen (OBL), Abraxane (ABX), and

Temozolomide (TMZ) in Metastatic Melanoma and Normal LDH. Poster # 16

Abstract No: 9027 Sunday, June 1, 2008.

-- Effect of the Addition of Oblimersen (Bcl-2 antisense) to

Fludarabine/Cyclophosphamide for Relapsed/Refractory Chronic

Lymphocytic Leukemia (CLL) on Survival in Patients Who Achieve CR/nPR:

Five-year Follow-up from a Randomized Phase III Study. Abstract # 7008

Monday, June 2, 2008.

-- Prognostic Impact of Baseline LDH on Survival Independent of Tumor

Burden in Advanced Melanoma: Results of Phase III Trial of

Oblimersen-Dacarbazine (OBL-DTIC) vs. DTIC. (Publication).

-- Short IV Infusion of Oblimersen (OBL) in Patients with Solid Tumors:

Safety and Pharmacokinetics. (Publication).

-- Pharmacokinetics of Albumin-bound Paclitaxel (ABX) in combination with

Temozolomide (TMZ) and Oblimersen Sodium (OBL) in Patients with

Advanced Melanoma. (Publication).

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medici
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Clinical Programs Featured at American Society of Hematology Meeting
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Genta Receives Key Patent Related to Oral Gallium Compound G4544
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
(Date:4/17/2015)... 2015 Inivata, a Cambridge, ... their presence at the 2015 American Association for Cancer Research ... Nitzan Rosenfeld and a poster presentation. Michael ... - 22 nd . The presentation, entitled ... , forms part of a session on Recent ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Equipment Rental and Leasing - Global Strategic Business ... report analyzes the worldwide markets for Medical Equipment Rental ... comprehensive analytics for the US, Japan ... World. Annual estimates and forecasts are provided ...
Breaking Medicine Technology:AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2
... UCB offers Cimzia(R) (certolizumab pegol), a treatment option ... arthritis and moderate to severe Crohn,s disease, to ... resulting from the UCB partnership with OXO(R) ... and OXO(R) in the development of the new ...
... Results Show Superior Decrease in Pain Scores Compared to ... presented the results of a six-month safety and efficacy ... at decreasing the pain of knee osteoarthritis (OA) at ... is superior to saline in decreasing pain at 26 ...
Cached Medicine Technology:Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 2Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 3Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 4Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 5Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 6Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 7Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 8Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 9Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 10Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 11Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 2Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 3
(Date:4/19/2015)... The American Institute for Cancer Research ... (“PROSHRED”) to host its second annual, nationwide Shred Cancer ... documents in order to raise funds for cancer research ... 6th event is being held at 20+ PROSHRED locations ... The time will vary at select locations. , Individuals ...
(Date:4/19/2015)... HealthPostures, LLC , a leading American ... it’s pioneering ergonomics products at the Wisconsin Safety and ... Professional Development Conference and Expo . The products, the ... in volume by call centers, educational organizations, retailers, government ... to a desk, the TaskMate Go 6350 and the ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... April 18, 2015 Insuranceautoquote.info has released ... online auto insurance quotes . , Clients can ... single website. The online environment provides important advantages for ... , Drivers who do not have coverage for ... during any season, day or hour. Many agencies offer ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com ... , "We had to run maintenance on our shipping ... Jennifer Ramirez, the PR Director. "It disrupted our regular ... we are back on track after having completed the ... changing phone systems which has not allowed some calls ...
Breaking Medicine News(10 mins):Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2
... in soy foods such as tufu, soy milk or soy ... , ,However, the soy foods should be made from raw ... this, soy-supplemented muffins, cereals or nutritional bars do not offer ... prepare these foods. ,Beneficial soy products include soy ...
... that resveratrol, a compound found in grapes and ... peptides, which cause the telltale senile plaques of ... antioxidant compounds with potential neuroprotective activities. Resveratrol is ... widely studied for their health benefits. It is ...
... New bird flu vaccine is to be developed from this ... from wild birds which has killed wild and migratory poultry ... Organization (WHO). //WHO has given orders to the Wildlife Conservation ... very helpful during a possible attack. The WCS team of ...
... fact that one third of our lifetime is spent in sleep. ... quantity. A new study conducted reveals the lack of adequate sleep ... And the mail villain held responsible- Of course stress! ... 1003 adults by the Gallup Organization for International Longevity Center-USA to ...
... aging molecule, Klotho named after the Greek God who spins ... believed to play a very important role in the aging ... symptoms of aging, while over expression is associated with an ... the blood. The working mechanism however remained unclear. A ...
... sounded against bird flu at the Kaziranga National Park in ... sanctuary around this time every year. // ,Wildlife staff ... park have been alerted about the possibility of migratory birds ... immediately if any unusual avian behaviour. A veterinary doctor has ...
Cached Medicine News:Health News:Lack of adequate sleep among people over 50 2
... Sling System is an innovative, safe and ... stress urinary incontinence in men following prostatectomy. ... who are not candidates for an artificial ... limited mental capacity or patient preference., ,InVance ...
... system is intended for the qualitative detection ... When performed according to these instructions, the ... clinical information, may aid in the determination ... diagnosis of VZV infections. This test is ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
ELISA kit for Varicella-zoster IgG....
Medicine Products: